| JXHS1800054 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2018-10-29 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-09-03 | view |
| JYHB2001171 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-07-04 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-09-04 | view |
| JYHB1701074 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2017-08-21 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-02-13 | view |
| JYHB2100140 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-02-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-09-23 | view |
| JYHB2000291 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-04-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-05-25 | view |
| JYHB1800012 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-01-12 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Approval Completed-Pending Certificated | 2018-02-01 | view |
| JYHB1800902 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-08-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-10-10 | view |
| JYHB2000760 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-06-18 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-08-18 | view |
| JXHL2000306 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-11-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-11-18 | view |
| JYHF1800015 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2018-02-07 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-03-06 | view |
| JXHS2000151 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-04-13 | view |
| JYHB1701518 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2017-12-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2017-12-20 | view |
| JXHL2100068 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-03-03 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2021-03-02 | view |
| JYHB2000759 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-06-18 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-08-18 | view |
| JXHL2000305 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-11-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-11-18 | view |
| JYHF1800014 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2018-02-07 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-03-06 | view |
| JXHS2000150 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-04-13 | view |
| JYHB1701519 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2017-12-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2017-12-20 | view |
| JXHL2100067 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-03-03 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2021-03-02 | view |
| JYHB1800901 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-08-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-10-10 | view |
